Achievements

Really fantastic start with the new Biotech portfolio. We cast a wide net given the nature of the field. Most of our stocks are highly speculative, but all are grounded in solid science. We currently hold 27 stocks.

I sold Exacta since it was in a non-taxable account, many holders will likely wait until next year to sell. Exacta finished with a stunning 49% gain in our 10-day hold.

Of the 27 stocks, we had 7 losers:

Penny stock XS FBLG was down 23%, BDTX down 15%, and ASPI down 22%. All others were only marginally down.

On the plus side, we had 18 winners:

NUVB up 72.2%, EXAS up 49%, GRAL up 33.9%, OLMA up 38%, five stocks up 20%, and six more up 10% or higher.

Wow. We can’t promise results like this every time, but we are working hard to keep finding the winners.